Insider filing · RYTM
Lynn A. Tetrault sold $1.0M of Rhythm Pharmaceuticals (RYTM)
Executed Sep 9 2024, disclosed Sep 11 2024, 2 days later.
Value, as filed
$1.0M
20,350 sh across 3 lots
Executed
Sep 9 2024
the trade date, as filed
Disclosed
Sep 11 2024
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
LT
Lynn A. Tetrault
Director
profile →
Lynn A. Tetrault (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Rhythm Pharmaceuticals, Inc. (RYTM). The largest single filing was $3.7M of RYTM (37,000 sh × $100.32, as filed), executed Jun 22.
The name
RYTM
Rhythm Pharmaceuticals, Inc.
RYTM · Healthcare · 47 filings in 24 months
ticker →
Healthcare · Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United State…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Lynn A. Tetrault in RYTM
RYTMSALE
Rhythm Pharmaceuticals, Inc.
$3.7M37,000 sh × $100.32
Exec Jun 22
Filed Jun 24 · 5:30 PM ET